Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts Details-
Title Grant Type Focus Area Country Application Due Date Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology Brazil, Chile, India, Italy, South Africa, Spain, United Kingdom Guideline Concordant Care and New Data for Patients with MIBC through la/mUCEducation Oncology USA Clinical Research Studies of Atirmociclib in HR+/HER2- and/or HER2+ Breast CancerRelease Date:Research Oncology Australia, Brazil, Canada, China, France, Germany, Italy, Japan, Korea, Mexico, Spain, Taiwan, USA, United Kingdom Quality Improvement Interventions to Enhance the Care of Patients Infected by MBL-CRE or S. maltophiliaRelease Date:Quality Improvement Inflammation & Immunology Australia, Chile, India, Italy, Spain, United Kingdom Advancing Real-World Evidence in Idiopathic Inflammatory Myopathies Through a German Disease RegistryRelease Date:Research Inflammation & Immunology Germany Real-World Evidence on Clinical Outcomes with ATM-AVI in Adult Patients with Stenotrophomonas maltophilia InfectionsRelease Date:Research Inflammation & Immunology China Real-World Evidence on Clinical Outcomes with Aztreonam-Avibactam (ATM-AVI) in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China Tissue Penetration and Correlation with Clinical Outcomes of ATM-AVI in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China Advancing Multidisciplinary Care in HemophiliaRelease Date:Quality Improvement Rare Disease China BCMA BsAb Educational Initiatives in 2L+ Relapsed/Refractory Multiple MyelomaRelease Date:Education Oncology USA -
Title Grant Type Focus Area Country Application Due Date Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)Release Date:Education Rare Disease USA Quality Improvement Grants to improve the early suspicion, identification, and the management of patients with ATTR-CMRelease Date:Quality Improvement Rare Disease Canada Develop Young Physicians to Lead the Increase in Preventive Awareness by VaccinationRelease Date:Education Vaccines Japan Optimizing maternal immunization practice and vaccination access during pregnancy in ItalyRelease Date:Quality Improvement Vaccines Italy Projects for Enhancing Regional Cancer TreatmentRelease Date:Partner: Japanese Society of Clinical OncologyQuality Improvement Oncology Japan Sickle Cell Disease (SCD) FellowshipRelease Date:Fellowship Rare Disease USA Cancer RegistryRelease Date:Research Oncology Congo, The Democratic Republic The Value of Standardized Diagnosis and Treatment in Patients with Moderate-to-Severe Atopic DermatitisRelease Date:Research Inflammation & Immunology China Real World Evidence of Abrocitinib in Adolescent Patients with Moderate-to-Severe Atopic DermatitisRelease Date:Research Inflammation & Immunology China Improving the Therapeutic Environment for Metastatic Breast CancerRelease Date:Education Oncology Japan Shared Decision-Making (SDM) in Lung CancerRelease Date:Education Oncology Japan Improving Care for Patients with Hodgkin and Non-Hodgkin’s LymphomaRelease Date:Education Oncology USA